Published in J Lipid Res on June 19, 2015
Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report. Arterioscler Thromb Vasc Biol (2016) 0.79
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ (1998) 7.48
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation (2007) 4.62
Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab (2009) 3.98
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet (2015) 3.79
Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol (1968) 3.20
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet (2008) 2.96
UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke (2002) 2.91
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). Diabetes Care (2005) 2.59
Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev (2012) 1.64
The determination of lipids and proteins in suction blister fluid. J Invest Dermatol (1979) 1.46
Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). J Biol Chem (1986) 1.41
Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system. Eur J Clin Invest (2006) 1.26
ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan. Diabetes (2009) 1.12
Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal (2014) 1.08
Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. J Lipid Res (1990) 1.05
Interstitial fluid: exchange of macromolecules between plasma and skin interstitium. Clin Physiol (1981) 0.98
Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis (1996) 0.97
Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus. Atherosclerosis (2012) 0.96
Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. Am J Med (1983) 0.87
HDL2 interferes with LDL association with arterial proteoglycans: a possible athero-protective effect. Atherosclerosis (2012) 0.86
Lipoprotein composition of human suction-blister interstitial fluid. J Lipid Res (1987) 0.84
Transvascular low-density lipoprotein transport in patients with diabetes mellitus (type 2): a noninvasive in vivo isotope technique. Arterioscler Thromb Vasc Biol (2002) 0.80
In vivo transfer of cholesterol from plasma into human aortic tissue. Scand J Clin Lab Invest Suppl (1987) 0.78
Interstitial fluid lipoproteins. Curr Opin Lipidol (2013) 0.77
Decreased interstitial apolipoprotein A-I levels in IDDM patients with diabetic nephropathy. Diabetes (1995) 0.77